课题基金 / 基金详情

Malaria Transporters as a novel target for Antimalarial Campaign

Malaria Transporters as a novel target for Antimalarial Campaign
疟疾转运蛋白作为抗疟运动的新目标
批准号:
9205623
负责人:
Ajit Jadhav
金额:
$1.9万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Ajit Jadhav的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project highlights: using miniaturized to 1536-well plate format with 8 different media, collections of MMV box, NPC and NCGC MIPE libraries were screened. The positive compounds are being tested for further compound selections. During this period, the NCGC has fostered and maintained over 180 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to over 100 high-throughput screens and nearly 60 medicinal chemistry campaigns, providing our collaborators and the general research community a wealth of publications and promising small molecule leads. In addition, the NCGC has undertaken a number of informatic challenges to make better use of existing drug and disease target information and provide the general public with easily accessible resources, further catalyzing the development of new therapies for human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Irreversible targeting of mammalian thioredoxin reductase 1 (TrxR1) for anticancer therapy
Phenotypic Screening to Identify Regulators of CFTR Localization
Selective inhibitors of citron rho kinase (CIT-K)
Selective inhibitors of citron rho kinase (CIT-K)
国内基金
海外基金
棉铃虫葡萄糖转运蛋白(Glucose transporters)的分子鉴定
  • 批准号:
    31601644
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    袁一杨
  • 依托单位: